In this issue:
Effect of metformin on invasive DFS in breast cancer
Breast cancers are immunogenic
Inflammatory diet increases breast cancer risk
Circulating tumour cells for prognostication before and after adjuvant chemotherapy
Adjuvant capecitabine-containing chemotherapy benefit and homologous recombination deficiency in early-stage TNBC
Adjuvant abemaciclib + endocrine therapy for high-risk early breast cancer
Heterogeneity from 18F-FDG PET/CT predicts immunotherapy outcome in metastatic TNBC
6×FEC vs. 4×doxorubicincyclophosphamide in operable node-negative breast cancer
Discontinuing adjuvant endocrine therapy in older patients with breast cancer
Neoadjuvant doxorubicin-cyclophosphamide then paclitaxel for early breast cancer
Please login below to download this issue (PDF)